Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05061706
What this trial is testing

Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Intra-Cellular Therapies, Inc. 480
Large-scale testing (Phase 3)Study completedNCT01942733
What this trial is testing

Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder

Who this might be right for
Sleep Disturbances
H. Lundbeck A/S 44
Not applicableTemporarily pausedNCT04178564
What this trial is testing

Major Memory 2: A Long-term Group Cognitive Stimulation Program

Who this might be right for
Neurocognitive DisordersDementiaCognitive Impairment+1 more
Rsocialform - Geriatria, Lda 70
Large-scale testing (Phase 3)Study completedNCT00225485
What this trial is testing

Study Evaluating Effexor XR in Elderly Patients With Major Depression.

Who this might be right for
Depression
Wyeth is now a wholly owned subsidiary of Pfizer 100
Testing effectiveness (Phase 2)WithdrawnNCT01189318
What this trial is testing

Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Ewha Womans University
Early research (Phase 1)Looking for participantsNCT03973268
What this trial is testing

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Who this might be right for
DepressionMajor Depressive DisorderMajor Depression
National Institute of Mental Health (NIMH) 70
Not applicableLooking for participantsNCT06729541
What this trial is testing

Development and Application of Precision Treatment Strategies for Common Mental Disorders

Who this might be right for
Depression - Major Depressive DisorderSchizophrenia DisordersBipolar Disorder (BD)
Peking University 600
Not applicableStudy completedNCT02043197
What this trial is testing

Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder

Who this might be right for
Depression
Abbott 300
Post-approval studies (Phase 4)Ended earlyNCT04093960
What this trial is testing

Escitalopram Plus PS128 vs. Escitalopram

Who this might be right for
Major Depression
Kaohsiung Kai-Suan Psychiatric Hospital 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT05434156
What this trial is testing

ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression

Who this might be right for
Healthy VolunteersMajor Depressive DisorderDepression
Eleusis Therapeutics 84
Not applicableLooking for participantsNCT05239780
What this trial is testing

Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients

Who this might be right for
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai 10
Not applicableUnknownNCT05767073
What this trial is testing

LIVES: Personalized Lifestyle Intervention for Patients With Depression

Who this might be right for
Cardiovascular RiskDepression, UnipolarDepression, Bipolar
University Medical Center Groningen 38
Not applicableUnknownNCT04684277
What this trial is testing

Internet-Based Interventions for MDD

Who this might be right for
DepressionMedication Adherence
Peking University 440
Not applicableUnknownNCT00192751
What this trial is testing

From Compliance to Alliance: Engaging Psychiatric Patients in Illness Management

Who this might be right for
Patients Diagnosed With Severe Mental Illness
Rambam Health Care Campus 150
Post-approval studies (Phase 4)Study completedNCT01541475
What this trial is testing

Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Ewha Womans University 60
Not applicableStudy completedNCT06114342
What this trial is testing

The Biological Specificity of Acupoints Between Major Depressive Disorder Patients and Healthy Controls

Who this might be right for
Major Depressive Disorder
Xiaomei Shao 184
Large-scale testing (Phase 3)Study completedNCT02279966
What this trial is testing

Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 152
Large-scale testing (Phase 3)Study completedNCT00225524
What this trial is testing

Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.

Who this might be right for
Depression
Wyeth is now a wholly owned subsidiary of Pfizer 150
Testing effectiveness (Phase 2)Study completedNCT01428804
What this trial is testing

Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression

Who this might be right for
Resistant Major Depression
Centre Hospitalier Universitaire de Besancon 24
Post-approval studies (Phase 4)Study completedNCT00401726
What this trial is testing

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

Who this might be right for
Depressive Disorder, Major
Wyeth is now a wholly owned subsidiary of Pfizer 537
Next Page